Goldman Sachs
AZN icon

Goldman Sachs’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$839M Buy
12,012,062
+230,214
+2% +$16.1M 0.11% 135
2025
Q1
$866M Buy
11,781,848
+1,393,251
+13% +$102M 0.14% 110
2024
Q4
$681M Sell
10,388,597
-1,657,688
-14% -$109M 0.11% 137
2024
Q3
$939M Sell
12,046,285
-450,065
-4% -$35.1M 0.15% 99
2024
Q2
$975M Buy
12,496,350
+210,235
+2% +$16.4M 0.16% 91
2024
Q1
$832M Buy
12,286,115
+752,637
+7% +$51M 0.15% 111
2023
Q4
$777M Buy
11,533,478
+449,999
+4% +$30.3M 0.14% 110
2023
Q3
$751M Buy
11,083,479
+483,775
+5% +$32.8M 0.16% 95
2023
Q2
$759M Buy
10,599,704
+1,313,594
+14% +$94M 0.16% 91
2023
Q1
$645M Buy
9,286,110
+1,534,625
+20% +$107M 0.15% 105
2022
Q4
$526M Buy
7,751,485
+1,000,884
+15% +$67.9M 0.13% 129
2022
Q3
$370M Buy
6,750,601
+345,216
+5% +$18.9M 0.09% 170
2022
Q2
$423M Sell
6,405,385
-825,637
-11% -$54.5M 0.11% 131
2022
Q1
$480M Buy
7,231,022
+948,560
+15% +$62.9M 0.1% 155
2021
Q4
$366M Sell
6,282,462
-5,241,096
-45% -$305M 0.07% 230
2021
Q3
$692M Sell
11,523,558
-3,107,844
-21% -$187M 0.15% 107
2021
Q2
$876M Buy
14,631,402
+5,160,216
+54% +$309M 0.2% 63
2021
Q1
$471M Buy
9,471,186
+1,231,318
+15% +$61.2M 0.12% 137
2020
Q4
$412M Buy
8,239,868
+1,940,998
+31% +$97M 0.11% 143
2020
Q3
$345M Sell
6,298,870
-1,643,098
-21% -$90M 0.1% 151
2020
Q2
$420M Buy
7,941,968
+16,444
+0.2% +$870K 0.13% 126
2020
Q1
$354M Buy
7,925,524
+1,085,098
+16% +$48.5M 0.12% 135
2019
Q4
$341M Buy
6,840,426
+201,827
+3% +$10.1M 0.09% 214
2019
Q3
$296M Buy
6,638,599
+1,583,054
+31% +$70.6M 0.09% 219
2019
Q2
$209M Sell
5,055,545
-359,212
-7% -$14.8M 0.06% 325
2019
Q1
$219M Buy
5,414,757
+2,139,012
+65% +$86.5M 0.07% 298
2018
Q4
$124M Buy
3,275,745
+301,774
+10% +$11.5M 0.04% 475
2018
Q3
$118M Buy
2,973,971
+684,089
+30% +$27.1M 0.03% 601
2018
Q2
$80.4M Sell
2,289,882
-1,606,463
-41% -$56.4M 0.02% 814
2018
Q1
$136M Buy
3,896,345
+798,923
+26% +$27.9M 0.03% 552
2017
Q4
$107M Buy
3,097,422
+100,391
+3% +$3.48M 0.03% 662
2017
Q3
$102M Sell
2,997,031
-1,193,754
-28% -$40.4M 0.02% 683
2017
Q2
$143M Buy
4,190,785
+1,253,906
+43% +$42.7M 0.04% 484
2017
Q1
$91.5M Buy
2,936,879
+897,565
+44% +$28M 0.02% 690
2016
Q4
$55.7M Buy
2,039,314
+103,179
+5% +$2.82M 0.02% 937
2016
Q3
$63.6M Sell
1,936,135
-368,198
-16% -$12.1M 0.02% 838
2016
Q2
$69.6M Buy
2,304,333
+295,932
+15% +$8.93M 0.02% 734
2016
Q1
$56.6M Buy
2,008,401
+339,579
+20% +$9.56M 0.02% 846
2015
Q4
$56.7M Buy
1,668,822
+87,439
+6% +$2.97M 0.02% 819
2015
Q3
$50.3M Buy
1,581,383
+1,080,960
+216% +$34.4M 0.02% 806
2015
Q2
$31.9M Buy
500,423
+115,384
+30% +$7.35M 0.01% 1118
2015
Q1
$26.3M Buy
385,039
+43,720
+13% +$2.99M 0.01% 1192
2014
Q4
$24M Sell
341,319
-230,015
-40% -$16.2M 0.01% 1220
2014
Q3
$40.8M Buy
571,334
+240,381
+73% +$17.2M 0.01% 896
2014
Q2
$24.6M Sell
330,953
-201,261
-38% -$15M 0.01% 1179
2014
Q1
$34.5M Buy
532,214
+334,418
+169% +$21.7M 0.01% 961
2013
Q4
$11.7M Sell
197,796
-21,288
-10% -$1.26M ﹤0.01% 1491
2013
Q3
$11.4M Sell
219,084
-54,925
-20% -$2.85M ﹤0.01% 1411
2013
Q2
$13M Buy
+274,009
New +$13M 0.01% 1243